Kayode K. Ojo
8Patents
1h-index
11Co-inventors
40Inventor score
Filing activity: Jul 30, 2012 → Jan 10, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9765037B2 | Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases | Emerging Cross-Sectional Technologies | 7 | Active |
| US9518026B2 | 5-aminopyrazole-4-carboxamide inhibitors of CDPK1 from T. gondii and C. parvum | Emerging Cross-Sectional Technologies | 1 | Active |
| US10307425B2 | Compositions and methods for treating toxoplasmosis, cryptosporidiosis and other apicomplexan protozoan related diseases | Emerging Cross-Sectional Technologies | 1 | Active |
| US9956214B2 | 5-aminopyrazole-4-carboxamide inhibitors of CDPK1 from T. gondii and C. parvum | Emerging Cross-Sectional Technologies | 1 | Active |
| US10544104B2 | Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases | Emerging Cross-Sectional Technologies | 1 | Active |
| US10632122B2 | Compositions and methods for treating toxoplasmosis, cryptosporidiosis and other apicomplexan protozoan related diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US10350211B2 | Bumped kinase inhibitor compositions and methods for treating cancer | Emerging Cross-Sectional Technologies | 0 | Active |
| US11247972B2 | Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.